Literature DB >> 15377611

Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle.

S P Oliver1, R A Almeida, B E Gillespie, S J Headrick, H H Dowlen, D L Johnson, K C Lamar, S T Chester, W M Moseley.   

Abstract

Streptococcus uberis is an important cause of mastitis in dairy cows throughout the world, particularly during the dry period, the period around calving, and during early lactation. Strategies for controlling Strep. uberis mastitis are poorly defined and are currently inadequate. Objectives of the present study were to evaluate efficacy of ceftiofur, a new broad-spectrum cephalosporin antibiotic, for treatment of experimentally induced Strep. uberis intramammary infections (IMI) in lactating dairy cows during early lactation and to determine whether extended therapy regimens enhanced efficacy of ceftiofur. Efficacy of extended ceftiofur intramammary therapy regimens was investigated in 37 mammary quarters of 23 dairy cows that developed clinical mastitis following experimental infection with Strep. uberis during early lactation. Cows that developed clinical mastitis during the challenge period were allocated randomly to 3 groups representing 3 different ceftiofur treatment regimens: 2-d (n = 7 mammary quarters), 5-d (n = 16 mammary quarters), and 8-d (n = 14 mammary quarters) treatment regimens. For all groups, 125 mg of ceftiofur hydrochloride was administered via intramammary infusion. A bacteriological cure was defined as an experimentally infected quarter that was treated and was bacteriologically negative for the presence of Strep. uberis at 7, 14, 21, and 28 d posttreatment. Percentage of Strep. uberis IMI eliminated was 43, 88, and 100% for the 2-, 5-, and 8-d ceftiofur treatment regimens, respectively. Both the 5- and 8-d ceftiofur extended therapy treatment regimens had significantly higher bacterial cure rates than the standard 2-d ceftiofur treatment regimen. The bacterial cure rate of the 8-d ceftiofur extended therapy group was marginally better (P = 0.052) than the 5-d ceftiofur extended therapy group. Results of this study indicate that ceftiofur therapy was effective for eliminating Strep. uberis experimental IMI, and 5- and 8-d extended ceftiofur therapy regimens were more effective than the standard 2-d treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377611     DOI: 10.3168/jds.S0022-0302(04)73468-2

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  13 in total

1.  Efficacy of conventional and extended intra-mammary treatment of persistent sub-clinical mastitis with cefquinome in lactating dairy cows.

Authors:  Reza Kasravi; Mahmoud Bolourchi; Nima Farzaneh; Hesam A Seifi; Abbas Barin; Parviz Hovareshti; Faramarz Gharagozlou
Journal:  Trop Anim Health Prod       Date:  2011-03-29       Impact factor: 1.559

Review 2.  Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle.

Authors:  John Barlow
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-09       Impact factor: 2.673

3.  Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial.

Authors:  Geoffrey Truchetti; Emile Bouchard; Luc Descôteaux; Daniel Scholl; Jean-Philippe Roy
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

4.  Efficacy of a botanical preparation for the intramammary treatment of clinical mastitis on an organic dairy farm.

Authors:  Pablo Pinedo; Hubert Karreman; Hans Bothe; Juan Velez; Carlos Risco
Journal:  Can Vet J       Date:  2013-05       Impact factor: 1.008

5.  Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations.

Authors:  A J Bradley; M J Green
Journal:  J Dairy Sci       Date:  2009-05       Impact factor: 4.034

6.  Acute coliform mastitis in buffaloes (Bubalus bubalis): clinical findings and treatment outcomes.

Authors:  Sabry A El-Khodery; Salama A Osman
Journal:  Trop Anim Health Prod       Date:  2008-02       Impact factor: 1.559

7.  SepM, a Streptococcal Protease Involved in Quorum Sensing, Displays Strict Substrate Specificity.

Authors:  Saswati Biswas; Luyang Cao; Albert Kim; Indranil Biswas
Journal:  J Bacteriol       Date:  2015-11-09       Impact factor: 3.490

8.  Treatment of mastitis during lactation.

Authors:  S Pyörälä
Journal:  Ir Vet J       Date:  2009-04-01       Impact factor: 2.146

9.  Episodes of clinical mastitis and its relationship with duration of treatment and seasonality in crossbred cows maintained in organized dairy farm.

Authors:  Narender Kumar; A Manimaran; A Kumaresan; L Sreela; Tapas Kumar Patbandha; Shiwani Tiwari; Subhash Chandra
Journal:  Vet World       Date:  2016-01-21

Review 10.  What Is Success? A Narrative Review of Research Evaluating Outcomes of Antibiotics Used for Treatment of Clinical Mastitis.

Authors:  Pamela L Ruegg
Journal:  Front Vet Sci       Date:  2021-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.